Homepage
Author:
Clene Inc.
Posted Date:
May 21, 2026
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
Clene Inc.
May 21, 2026
Clene Announces $7 Million Underwritten Offering of Common Stock
Clene Inc.
May 5, 2026
Clene to Present at Upcoming May Conferences
Clene Inc.
May 5, 2026
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
Clene Inc.
May 4, 2026
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights
Clene Inc.
March 12, 2026
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts
Clene Inc.
February 24, 2026
Clene to Present at the Emerging Growth Conference
Clene Inc.
February 19, 2026
